These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16650839)

  • 41. Genetic mutations and arrhythmia: simulation from DNA to electrocardiogram.
    Zhu ZI; Clancy CE
    J Electrocardiol; 2007; 40(6 Suppl):S47-50. PubMed ID: 17993328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biology of cardiac sodium channel Nav1.5 expression.
    Rook MB; Evers MM; Vos MA; Bierhuizen MF
    Cardiovasc Res; 2012 Jan; 93(1):12-23. PubMed ID: 21937582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins.
    Tuvia S; Buhusi M; Davis L; Reedy M; Bennett V
    J Cell Biol; 1999 Nov; 147(5):995-1008. PubMed ID: 10579720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evolving role of ankyrin-B in cardiovascular disease.
    Koenig SN; Mohler PJ
    Heart Rhythm; 2017 Dec; 14(12):1884-1889. PubMed ID: 28765088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene expression of stretch-activated channels and mechanoelectric feedback in the heart.
    Kelly D; Mackenzie L; Hunter P; Smaill B; Saint DA
    Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):642-8. PubMed ID: 16789934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.
    Le Scouarnec S; Bhasin N; Vieyres C; Hund TJ; Cunha SR; Koval O; Marionneau C; Chen B; Wu Y; Demolombe S; Song LS; Le Marec H; Probst V; Schott JJ; Anderson ME; Mohler PJ
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15617-22. PubMed ID: 18832177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.
    Cunha SR; Hund TJ; Hashemi S; Voigt N; Li N; Wright P; Koval O; Li J; Gudmundsson H; Gumina RJ; Karck M; Schott JJ; Probst V; Le Marec H; Anderson ME; Dobrev D; Wehrens XH; Mohler PJ
    Circulation; 2011 Sep; 124(11):1212-22. PubMed ID: 21859974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.
    Bhasin N; Cunha SR; Mudannayake M; Gigena MS; Rogers TB; Mohler PJ
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H109-19. PubMed ID: 17416611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
    Mohler PJ; Splawski I; Napolitano C; Bottelli G; Sharpe L; Timothy K; Priori SG; Keating MT; Bennett V
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9137-42. PubMed ID: 15178757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defects in cardiac conduction system lineages and malignant arrhythmias: developmental pathways and disease.
    St Amand TR; Lu JT; Chien KR
    Novartis Found Symp; 2003; 250():260-70; discussion 271-5, 276-9. PubMed ID: 12956335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.
    Smith SA; Sturm AC; Curran J; Kline CF; Little SC; Bonilla IM; Long VP; Makara M; Polina I; Hughes LD; Webb TR; Wei Z; Wright P; Voigt N; Bhakta D; Spoonamore KG; Zhang C; Weiss R; Binkley PF; Janssen PM; Kilic A; Higgins RS; Sun M; Ma J; Dobrev D; Zhang M; Carnes CA; Vatta M; Rasband MN; Hund TJ; Mohler PJ
    Circulation; 2015 Feb; 131(8):695-708. PubMed ID: 25632041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ankyrins and Spectrins in Cardiovascular Biology and Disease.
    El Refaey MM; Mohler PJ
    Front Physiol; 2017; 8():852. PubMed ID: 29163198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium channel inactivation in heart: a novel role of the carboxy-terminal domain.
    Kass RS
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S21-S25. PubMed ID: 16686678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of microRNA in cardiac excitability.
    Wang Z
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):460-70. PubMed ID: 20588186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice.
    Chauhan VS; Tuvia S; Buhusi M; Bennett V; Grant AO
    Circ Res; 2000 Mar; 86(4):441-7. PubMed ID: 10700449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pleiotropic Ankyrins: Scaffolds for Ion Channels and Transporters.
    Stevens SR; Rasband MN
    Channels (Austin); 2022 Dec; 16(1):216-229. PubMed ID: 36082411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin.
    Bennett V; Healy J
    Trends Mol Med; 2008 Jan; 14(1):28-36. PubMed ID: 18083066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.
    Mohler PJ; Davis JQ; Bennett V
    PLoS Biol; 2005 Dec; 3(12):e423. PubMed ID: 16292983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-binding role of betaII-spectrin ankyrin-binding domain.
    Bok E; Plazuk E; Hryniewicz-Jankowska A; Chorzalska A; Szmaj A; Dubielecka PM; Stebelska K; Diakowski W; Lisowski M; Langner M; Sikorski AF
    Cell Biol Int; 2007 Dec; 31(12):1482-94. PubMed ID: 17716929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.
    Mohler PJ; Schott JJ; Gramolini AO; Dilly KW; Guatimosim S; duBell WH; Song LS; Haurogné K; Kyndt F; Ali ME; Rogers TB; Lederer WJ; Escande D; Le Marec H; Bennett V
    Nature; 2003 Feb; 421(6923):634-9. PubMed ID: 12571597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.